Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04836481 · ClinicalTrials.gov registry record
A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 10
- Enrollment target
NCT04836481: Completed study, sponsored by University of Cincinnati.
NCT04836481 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04836481 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study aims is to describe the pharmacokinetic properties of levetiracetam through measurement of serum concentrations in critically ill, severe traumatic brain injury patients.
Primary Outcome
Serum levetiracetam concentration collected at 0.5 hours after target dose for sampling
Interventions
- OTHER Serum Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2023-10-01 |
What the finished NCT04836481 record still lists
NCT04836481 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Serum Sample Collection is the first listed.
NCT04836481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04836481 about?
NCT04836481 is a clinical study titled "A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury". This study aims is to describe the pharmacokinetic properties of levetiracetam through measurement of serum concentrations in critically ill, severe traumatic brain injury patients.
What is the current status of trial NCT04836481?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2021-01-01. Estimated completion is 2023-10-01.
What interventions are being tested in trial NCT04836481?
The interventions under investigation include: Serum Sample Collection (OTHER).
Who is sponsoring clinical trial NCT04836481?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI